✦ LIBER ✦

W1017 Clinical and Persistency Outcomes in Hepatitis C Patients Treated with Peginterferon Alfa-2a or Peginterferon Alfa-2b Plus Ribavirin

✍ Scribed by Hassanein, Tarek; Ye, Xin; Chu, Teng-Chiao; Brixner, Diana

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

792 CLINICAL AND PERSISTENCY OUTCOMES IN

✍ T.I. Hassanein; X. Ye; W.A. Blumentals; D.I. Brixner 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 69 KB

Peginterferon alfa-2a/ribavirin in hepat

✍ V. K. RUSTGI; S. ESPOSITO; F. M. HAMZEH; M. L. SHIFFMAN 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 87 KB

Peginterferon Alfa-2a Plus Ribavirin Is

✍ Antonio Ascione; Massimo De Luca; Maria Teresa Tartaglione; Filippo Lampasi; Gio 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 269 KB

Pharmacoeconomic analysis of the treatme

✍ Turnes, Juan; Romero-Gómez, Manuel; Planas, Ramón; Solà, Ricard; García-Samanieg 📂 Article 📅 2013 🏛 Elsevier Science 🌐 Spanish ⚖ 610 KB

PIN45 COST-EFFECTIVENESS ANALYSIS OF TRE

✍ Ventayol-Bosch, P; Rubio-Terrés, C; García-Samaniego, J; Planas, R; Solà-Lamogli 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 77 KB

PIN92 Patient Reported Outcomes Among Ch

✍ A. Olveira; D. Rincon; M. Diago; J. Crespo; J.L. Calleja; J. Salmeron; R. Andrad 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 61 KB